Navidea Biopharmaceuticals ROA 2006-2019 | NAVB
Current and historical return on assets (ROA) values for Navidea Biopharmaceuticals (NAVB) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Navidea Biopharmaceuticals ROA for the three months ending September 30, 2019 was -182.08%.
| Navidea Biopharmaceuticals ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2019-09-30 | $-0.01B | $0.01B | -176.00% |
| 2019-06-30 | $-0.01B | $0.01B | -165.52% |
| 2019-03-31 | $-0.01B | $0.01B | -146.67% |
| 2018-12-31 | $-0.02B | $0.01B | -148.84% |
| 2018-09-30 | $-0.02B | $0.01B | -119.30% |
| 2018-06-30 | $-0.01B | $0.01B | -78.87% |
| 2018-03-31 | $-0.02B | $0.02B | -77.27% |
| 2017-12-31 | $0.08B | $0.02B | 295.15% |
| 2017-09-30 | $0.08B | $0.02B | 323.40% |
| 2017-06-30 | $0.08B | $0.03B | 375.61% |
| 2017-03-31 | $0.08B | $0.03B | 461.54% |
| 2016-12-31 | $-0.02B | $0.01B | -136.36% |
| 2016-09-30 | $-0.01B | $0.01B | -119.15% |
| 2016-06-30 | $-0.02B | $0.01B | -166.04% |
| 2016-03-31 | $-0.03B | $0.01B | -151.52% |
| 2015-12-31 | $-0.03B | $0.02B | -172.31% |
| 2015-09-30 | $-0.03B | $0.02B | -206.45% |
| 2015-06-30 | $-0.03B | $0.02B | -196.83% |
| 2015-03-31 | $-0.03B | $0.01B | -190.77% |
| 2014-12-31 | $-0.04B | $0.01B | -165.52% |
| 2014-09-30 | $-0.04B | $0.02B | -149.57% |
| 2014-06-30 | $-0.05B | $0.02B | -127.89% |
| 2014-03-31 | $-0.05B | $0.03B | -122.08% |
| 2013-12-31 | $-0.04B | $0.04B | -124.44% |
| 2013-09-30 | $-0.04B | $0.05B | -130.84% |
| 2013-06-30 | $-0.03B | $0.03B | -185.92% |
| 2013-03-31 | $-0.03B | $0.01B | -193.33% |
| 2012-12-31 | $-0.03B | $0.01B | -163.38% |
| 2012-09-30 | $-0.03B | $0.01B | -133.33% |
| 2012-06-30 | $-0.00B | $0.02B | -3.67% |
| 2012-03-31 | $0.00B | $0.03B | 11.88% |
| 2011-12-31 | $0.01B | $0.03B | 26.67% |
| 2011-09-30 | $0.01B | $0.03B | 68.57% |
| 2011-06-30 | $-0.01B | $0.01B | -90.91% |
| 2011-03-31 | $-0.06B | $0.01B | -590.00% |
| 2010-12-31 | $-0.06B | $0.01B | -662.86% |
| 2010-09-30 | $-0.06B | $0.01B | -678.79% |
| 2010-06-30 | $-0.08B | $0.01B | -902.86% |
| 2010-03-31 | $-0.04B | $0.01B | -491.43% |
| 2009-12-31 | $-0.04B | $0.01B | -445.71% |
| 2009-09-30 | $-0.04B | $0.01B | -444.44% |
| 2009-06-30 | $-0.02B | $0.01B | -200.00% |
| 2009-03-31 | $-0.00B | $0.01B | -35.29% |
| 2008-12-31 | $-0.01B | $0.01B | -64.52% |
| 2008-09-30 | $-0.01B | $0.01B | -85.71% |
| 2008-06-30 | $-0.01B | $0.01B | -74.07% |
| 2008-03-31 | $-0.01B | $0.01B | -80.00% |
| 2007-12-31 | $-0.01B | $0.01B | -76.92% |
| 2007-09-30 | $-0.00B | $0.01B | -59.26% |
| 2007-06-30 | $-0.01B | $0.01B | -68.97% |
| 2007-03-31 | $-0.01B | $0.01B | -60.61% |
| 2006-12-31 | $-0.01B | $0.01B | -54.05% |
| 2006-09-30 | $-0.01B | $0.01B | -48.78% |
| 2006-06-30 | $-0.00B | $0.01B | -35.56% |
| 2006-03-31 | $-0.00B | $0.01B | -32.65% |
| 2005-12-31 | $-0.00B | $0.01B | -30.19% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.016B | $0.001B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $126.713B | 26.25 |
| Intuitive Surgical (ISRG) | United States | $67.126B | 52.75 |
| Edwards Lifesciences (EW) | United States | $50.674B | 46.01 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $22.155B | 14.99 |
| IDEXX Laboratories (IDXX) | United States | $21.605B | 52.25 |
| DexCom (DXCM) | United States | $20.759B | 185.90 |
| Olympus (OCPNY) | Japan | $20.718B | 155.59 |
| Teleflex (TFX) | United States | $16.586B | 33.67 |
| Sysmex ADR (SSMXY) | Japan | $14.548B | 39.16 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.403B | 0.00 |
| Hologic (HOLX) | United States | $14.019B | 21.43 |
| STERIS (STE) | Ireland | $12.968B | 28.64 |
| Varian Medical Systems (VAR) | United States | $12.656B | 30.01 |
| ABIOMED (ABMD) | United States | $8.537B | 46.46 |
| Masimo (MASI) | United States | $8.297B | 49.54 |
| Penumbra (PEN) | United States | $5.920B | 192.69 |
| Globus Medical (GMED) | United States | $5.655B | 34.90 |
| SARTORIUS AG (SARTF) | Germany | $5.614B | 49.28 |
| Integra LifeSciences Holdings (IART) | United States | $5.296B | 22.76 |
| Elekta AB (EKTAY) | Sweden | $4.665B | 35.91 |
| LivaNova (LIVN) | United Kingdom | $3.960B | 28.51 |
| Wright Medical Group (WMGI) | Netherlands | $3.756B | 227.69 |
| Tandem Diabetes Care (TNDM) | United States | $3.657B | 0.00 |
| Nevro (NVRO) | United States | $3.515B | 0.00 |
| Cantel Medical (CMD) | United States | $3.311B | 32.81 |
| Integer Holdings (ITGR) | United States | $2.519B | 17.24 |
| Nihon Kohden (NHNKY) | Japan | $2.390B | 24.05 |
| Glaukos (GKOS) | United States | $2.173B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.579B | 31.08 |
| Inogen (INGN) | United States | $1.579B | 49.85 |
| Veracyte (VCYT) | United States | $1.465B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.194B | 136.39 |
| Mesa Laboratories (MLAB) | United States | $1.092B | 40.49 |
| Silk Road Medical (SILK) | United States | $1.078B | 0.00 |
| Natus Medical (NTUS) | United States | $1.062B | 25.52 |
| OPKO Health (OPK) | United States | $1.058B | 0.00 |
| CryoLife (CRY) | United States | $0.926B | 94.92 |
| Luminex (LMNX) | United States | $0.920B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.858B | 28.50 |
| Accelerate Diagnostics (AXDX) | United States | $0.848B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.776B | 0.00 |
| Intersect ENT (XENT) | United States | $0.674B | 0.00 |
| AxoGen (AXGN) | United States | $0.663B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.589B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.575B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.572B | 20.55 |
| Si-Bone (SIBN) | United States | $0.455B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.449B | 13.58 |
| Alphatec Holdings (ATEC) | United States | $0.422B | 0.00 |
| Sientra (SIEN) | United States | $0.409B | 0.00 |
| ViewRay (VRAY) | United States | $0.400B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.322B | 0.00 |
| Stereotaxis (STXS) | United States | $0.300B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.280B | 38.92 |
| IRadimed (IRMD) | United States | $0.259B | 36.44 |
| Accuray (ARAY) | United States | $0.254B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.246B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.230B | 64.20 |
| Fluidigm (FLDM) | United States | $0.175B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.139B | 36.85 |
| RTI Surgical (RTIX) | United States | $0.139B | 37.60 |
| ConforMIS (CFMS) | United States | $0.112B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.111B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.101B | 0.00 |
| Neuronetics (STIM) | United States | $0.085B | 0.00 |
| Electromed (ELMD) | United States | $0.084B | 30.15 |
| Restoration Robotics (VERO) | Canada | $0.084B | 0.00 |
| Vermillion (VRML) | United States | $0.069B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.062B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.056B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.056B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.049B | 0.00 |
| TransEnterix (TRXC) | United States | $0.048B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.042B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.036B | 0.00 |
| Neovasc (NVCN) | Canada | $0.022B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.022B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.019B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.018B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.018B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.016B | 0.00 |
| Avinger (AVGR) | United States | $0.015B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.015B | 21.17 |
| OBALON THERPTCS (OBLN) | United States | $0.014B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.009B | 0.00 |
| Micron Solutions (MICR) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.007B | 0.00 |
| Dynatronics (DYNT) | United States | $0.006B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| InspireMD (NSPR) | Israel | $0.003B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.003B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.001B | 0.00 |
